CRH Medical Corp (CVE:CRM) shares hit a new 52-week low during mid-day trading on Friday . The company traded as low as C$2.34 and last traded at C$2.40, with a volume of shares trading hands.
Separately, CIBC lowered shares of CRH Medical Corp from a “sector outperform” rating to a “sector perform” rating in a research note on Monday, July 17th.
COPYRIGHT VIOLATION NOTICE: “CRH Medical Corp (CRM) Reaches New 52-Week Low at $2.34” was originally reported by Community Financial News and is the property of of Community Financial News. If you are accessing this piece on another website, it was illegally copied and republished in violation of international copyright & trademark laws. The original version of this piece can be accessed at https://www.com-unik.info/2017/11/05/crh-medical-corp-crm-reaches-new-52-week-low-at-2-34.html.
CRH Medical Corp Company Profile
CRH Medical Corporation (CRH) specializes in the distribution of medical products directly to physicians, particularly those in the gastroenterologist community. The Company’s lead product, the CRH O’Regan System, is a single use, disposable, hemorrhoid treatment that is used in treating hemorrhoid grades I-IV.
What are top analysts saying about CRH Medical Corp? - Enter your email address in the form below to receive our free daily email newsletter that contains the latest headlines and analysts' recommendations for for CRH Medical Corp and related companies.